Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 2 (2006), Issue 2 (February)

1. Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids.
   Drug Alcohol Depend, 81(3): 241-9. [Abstract] [Full-text]
2. Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
   Pharmacoepidemiol Drug Saf, 15(2): 99-105. [Abstract] [Full-text]
3. Exposure-time-varying hazard function ratios in case-control studies of drug effects.
   Pharmacoepidemiol Drug Saf, 15(2): 81-92. [Abstract] [Full-text]
4. What is behind smoking among pharmacy students: a quantitative and qualitative study from Turkey.
   Subst Use Misuse, 41(3): 405-14. [Abstract] [Full-text]
5. Psychopharmacology in adolescent medicine.
   Adolesc Med Clin, 17(1): 165-81. [Abstract] [Full-text]
6. DNA based customized nutraceutical "gene therapy" utilizing a genoscore: a hypothesized paradigm shift of a novel approach to the diagnosis, stratification, prognosis and treatment of inflammatory processes in the human.
   Med Hypotheses, 66(5): 1008-18. [Abstract] [Full-text]
7. Applications of mass spectrometry in early stages of target based drug discovery.
   J Pharm Biomed Anal, 40(3): 528-38. [Abstract] [Full-text]
8. A call for the creation of personalized medicine databases.
   Nat Rev Drug Discov, 5(1): 23-6. [Abstract] [Full-text]
9. Curriculum development in pharmacotherapy: testing the ability of preclinical medical students to learn therapeutic problem solving in a randomized controlled trial.
   Br J Clin Pharmacol, 61(3): 345-51. [Abstract] [Full-text]
10. Cellular stress responses and molecular mechanisms of nephrotoxicity.
    Toxicol Lett, 162(1): 83-93. [Abstract] [Full-text]
11. Genetic basis of toxic reactions to drugs and chemicals.
    Toxicol Lett, 162(1): 16-28. [Abstract] [Full-text]
12. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.
    Nat Rev Cancer, 6(2): 130-40. [Abstract] [Full-text]
13. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
    Nat Rev Cancer, 6(2): 117-29. [Abstract] [Full-text]
14. Pharmacogenetics, adverse drug reactions and public health.
    Community Genet, 9(1): 50-4. [Abstract] [Full-text]
15. So many studies, too few subjects: establishing functional relevance of genetic polymorphisms on pharmacokinetics.
    J Clin Pharmacol, 46(3): 258-64. [Abstract] [Full-text]
16. Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
    NeuroRx, 3(1): 106-16. [Abstract] [Full-text]
17. Evaluation of cognitive function in weanling rats: a review of methods suitable for chemical screening.
    Neurotoxicol Teratol, 28(1): 144-61. [Abstract] [Full-text]
18. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin.
    Thromb Haemost, 95(2): 205-11. [Abstract] [Full-text]
19. Longitudinal observational studies to study the efficacy-effectiveness gap in drug therapy: application to mild and moderate dementia.
    Nurs Clin North Am, 41(1): 105-17, vii. [Abstract] [Full-text]
20. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Pharmacogenet Genomics, 16(3): 219-27. [Abstract] [Full-text]
21. Experimental validation of data mined single nucleotide polymorphisms from several databases and consecutive dbSNP builds.
    Pharmacogenet Genomics, 16(3): 207-17. [Abstract] [Full-text]
22. P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx.
    Pharmacogenet Genomics, 16(3): 199-205. [Abstract] [Full-text]
23. Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.
    Pharmacogenet Genomics, 16(3): 191-8. [Abstract] [Full-text]
24. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.
    Pharmacogenet Genomics, 16(3): 183-90. [Abstract] [Full-text]
25. Rat brain DNA transcript profile of halothane and isoflurane exposure.
    Pharmacogenet Genomics, 16(3): 171-82. [Abstract] [Full-text]
26. Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis.
    Pharmacogenet Genomics, 16(3): 159-69. [Abstract] [Full-text]
27. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.
    Pharmacogenet Genomics, 16(3): 151-7. [Abstract] [Full-text]

© 2005-2013 Pharmacology Research Today. All Rights Reserved.